| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA676676 | F | In vitro growth inhibition against Entamoeba histolytica | Entamoeba histolytica | 102 | organism-based format | Scientific Literature | ||
| 2. | ALA679572 | B | Inhibitory activity against Leishmania major Farnesyl diphosphate synthase | Leishmania major | 43 | single protein format | Scientific Literature | ||
| 3. | ALA689504 | F | Percent decrease of amebic liver abscess (mg) formation in Entamoeba histolytica infected hamsters (treated at 10 mg/kg ip once a day for 5 days) | Cricetulus griseus | 5 | organism-based format | Scientific Literature | ||
| 4. | ALA689505 | F | Percent decrease of normal liver weight (mg) in Entamoeba histolytica infected hamsters (treated at 10 mg/kg ip once a day for 5 days) | Cricetulus griseus | 5 | organism-based format | Scientific Literature | ||
| 5. | ALA690768 | F | Mean effect on amebic liver abscess (mg) formation in Entamoeba histolytica infected hamsters (treated at 10 mg/kg ip once a day for 5 days) | Cricetulus griseus | 5 | organism-based format | Scientific Literature | ||
| 6. | ALA690769 | F | Mean effect on normal liver weight (mg) in Entamoeba histolytica infected hamsters (treated at 10 mg/kg ip once a day for 5 days) | Cricetulus griseus | 5 | organism-based format | Scientific Literature | ||
| 7. | ALA700364 | T | Toxicity evaluated against human nasopharyngeal carcinoma KB cell line | Homo sapiens | 102 | cell-based format | Scientific Literature | ||
| 8. | ALA769481 | F | In vitro growth inhibition against Plasmodium falciparum | Plasmodium falciparum | 102 | organism-based format | Scientific Literature | ||
| 9. | ALA878723 | F | Effective dose in inhibiting osteoclastic bone resorption | Rattus norvegicus | 55 | assay format | Scientific Literature | ||
| 10. | ALA799889 | F | Negative logarithm of inhibitory concentration against bone resorption | Rattus norvegicus | 55 | assay format | Scientific Literature | ||
| 11. | ALA808362 | F | Effective dose after subcutaneous administration to TPTX rats for 50% reduction of hypercalcemia | Rattus norvegicus | 102 | organism-based format | Scientific Literature | ||
| 12. | ALA851069 | A | Therapeutic index was expressed as ratio of LD50 for KB cell line to IC50 against Entamoeba histolytica | 47 | cell-based format | Scientific Literature | |||
| 13. | ALA881256 | A | Therapeutic index was expressed as ratio of LD50 for KB cell line to IC50 against Plasmodium falciparum | 35 | cell-based format | Scientific Literature | |||
| 14. | ALA880254 | B | Inhibition of recombinant Trypanosoma brucei soluble vacuolar pyrophosphatase expressed in Escherichia coli | Trypanosoma brucei | 81 | assay format | Scientific Literature | ||
| 15. | ALA883185 | F | Ratio of ED50 against KB cell line to that of IC50 of TbVSP1 | 34 | cell-based format | Scientific Literature | |||
| 16. | ALA872247 | F | Dose to inhibit the growth of human KB carcinoma cell line | Homo sapiens | 34 | cell-based format | Scientific Literature | ||
| 17. | ALA865780 | B | Inhibitory activity against Trypanosoma cruzi hexokinase | Trypanosoma cruzi | 42 | single protein format | Scientific Literature | ||
| 18. | ALA863956 | F | Cytotoxicity in human nasopharyngeal carcinoma KB cell line | Homo sapiens | 32 | cell-based format | Scientific Literature | ||
| 19. | ALA865754 | A | Therapeutic index TI=LD50(KB)/IC50(TcHK) | 32 | assay format | Scientific Literature | |||
| 20. | ALA865755 | F | Cytotoxicity to Dictyostelium discoideum | Dictyostelium discoideum | 32 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!